Group 1: Sales Strategy - The company maintains a dual-channel sales strategy, balancing online and offline sales with distinct product offerings for each channel [2] - Offline sales focus on series targeting customers aged 35 and above in lower-tier cities, with average transaction prices between 300-500 [2] - Online sales emphasize high-volume products aimed at customers aged 25-35 in first and second-tier cities, with average transaction prices between 200-300 [2] Group 2: Pricing and Brand Management - The company aims to utilize key opinion leaders (KOLs) without becoming overly reliant on them, enforcing strict internal policies against price cuts and market saturation [3] - Price control is a critical focus for the company, which will continue to be emphasized in 2024 [3] Group 3: Product Development and Innovation - The company has developed SPG, a polysaccharide with multiple benefits, including hydration and repair, based on a dual fermentation system [4] - The company is a leader in recombinant collagen technology in China, with ongoing investments in research and marketing to strengthen its competitive edge [4] - As of June 2023, the company has filed 457 patents, with 349 being invention patents, and has received 241 authorized patents, indicating a strong focus on innovation [4] Group 4: Research and Development - The company has a clear focus on eye care and anti-aging, supported by a robust R&D framework that has enabled a swift transition to online channels [4] - The company has been recognized as a national high-tech enterprise and has received various accolades for its technological advancements [4] - The company collaborates with multiple research institutions and universities to drive innovation in skin health and beauty [4]
丸美股份(603983) - 广东丸美生物技术股份有限公司投资者关系活动记录表